Evaluation and Management of Nutritional Consequences of Chronic Liver Diseases
- PMID: 37571424
- PMCID: PMC10421025
- DOI: 10.3390/nu15153487
Evaluation and Management of Nutritional Consequences of Chronic Liver Diseases
Abstract
Liver diseases are the major predisposing conditions for the development of malnutrition, sarcopenia, and frailty. Recently, the mechanism of the onset of these complications has been better established. Regardless of the etiology of the underlying liver disease, the clinical manifestations are common. The main consequences are impaired dietary intake, altered macro- and micronutrient metabolism, energy metabolism disturbances, an increase in energy expenditure, nutrient malabsorption, sarcopenia, frailty, and osteopathy. These complications have direct effects on clinical outcomes, survival, and quality of life. The nutritional status should be assessed systematically and periodically during follow-up in these patients. Maintaining and preserving an adequate nutritional status is crucial and should be a mainstay of treatment. Although general nutritional interventions have been established, special considerations are needed in specific settings such as decompensated cirrhosis, alcohol-related liver disease, and metabolic-dysfunction-associated fatty liver disease. In this review, we summarize the physiopathology and factors that impact the nutritional status of liver disease. We review how to assess malnutrition and sarcopenia and how to prevent and manage these complications in this setting.
Keywords: alcohol-related liver disease; cirrhosis; frailty; liver transplantation; malnutrition; metabolic dysfunction-associated fatty liver disease; sarcopenia.
Conflict of interest statement
The authors declare no conflict of interest.
Figures





Similar articles
-
Impact of Liver and Pancreas Diseases on Nutritional Status.Nutrients. 2021 May 13;13(5):1650. doi: 10.3390/nu13051650. Nutrients. 2021. PMID: 34068295 Free PMC article. Review.
-
Frailty, Sarcopenia, and Malnutrition in Cirrhotic Patients.Clin Liver Dis. 2019 Nov;23(4):589-605. doi: 10.1016/j.cld.2019.06.001. Epub 2019 Aug 21. Clin Liver Dis. 2019. PMID: 31563213 Review.
-
Review article: malnutrition/sarcopenia and frailty in patients with cirrhosis.Aliment Pharmacol Ther. 2020 Jan;51(1):64-77. doi: 10.1111/apt.15571. Epub 2019 Nov 8. Aliment Pharmacol Ther. 2020. PMID: 31701570 Review.
-
Dysgeusia in MASLD-related advanced chronic liver disease (ACLD): a silent driver towards the "Bermuda" triangle of malnutrition-sarcopenia-frailty severely affecting prognosis.Nutr J. 2025 Jan 16;24(1):10. doi: 10.1186/s12937-025-01074-z. Nutr J. 2025. PMID: 39819605 Free PMC article. Review.
-
Sarcopenia in cirrhosis: a clinical practice review.Ann Palliat Med. 2025 May;14(3):255-268. doi: 10.21037/apm-24-173. Ann Palliat Med. 2025. PMID: 40511569 Review.
Cited by
-
Systemic complications and management strategies in liver cancer patients undergoing interventional therapy.World J Gastrointest Surg. 2025 Jun 27;17(6):104883. doi: 10.4240/wjgs.v17.i6.104883. World J Gastrointest Surg. 2025. PMID: 40584495 Free PMC article.
-
Screening and assessment of malnutrition in patients with liver cirrhosis.Front Nutr. 2024 Jul 18;11:1398690. doi: 10.3389/fnut.2024.1398690. eCollection 2024. Front Nutr. 2024. PMID: 39091687 Free PMC article. Review.
-
Influence of subcutaneous adipose tissue index on prognosis in cirrhotic patients following endoscopic therapy: a retrospective cohort study.Lipids Health Dis. 2024 Jan 8;23(1):7. doi: 10.1186/s12944-023-01996-9. Lipids Health Dis. 2024. PMID: 38185678 Free PMC article.
References
-
- Lai J.C., Tandon P., Bernal W., Tapper E.B., Ekong U., Dasarathy S., Carey E.J. Malnutrition, Frailty, and Sarcopenia in Patients with Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology. 2021;74:1611–1644. doi: 10.1002/hep.32049. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical